The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Open accessAbstract
The demonstration in the 1960s that cis-diammine-dichloroplatinum(II), or cisplatin, inhibits cellular division of Escherichia coli led to the subsequent discovery that this simple coordination compound is also an effective antitumor agent in mouse models. Subsequent studies validated cisplatin as an effective anticancer agent in humans as well, and FDA approval of cisplatin for the treatment of metastatic ovarian and testicular cancers was granted in 1978. Its introduction as a chemotherapeutic agent significantly improved the survival outlook for many cancer patients; the cure rate for testicular cancer before the approval of cisplatin was less than 10%, significantly lower than the 90% cure rate attained with modern platinum chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Self-citationInhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Self-citationMolecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Taylor-Pashow, K. M. L., Della Rocca, J., Xie, Z., Tran, S., & Lin, W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906198y · Cited by 1,522
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Self-citationFichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Self-citationShen, D.-W., Pouliot, L. M., Hall, M. D., & Gottesman, M. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005637 · Cited by 955
Fuertes, M. A., Alonso, C., & Pérez, J. M. (2003) · Chemical Reviews · doi:10.1021/cr020010d · Cited by 893
Bosl, G. J., & Motzer, R. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370406 · Cited by 891
Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995) · Nature · doi:10.1038/377649a0 · Cited by 769
Self-citationGalanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721
Dhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, S. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803036e · Cited by 700
Self-citationTargeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Self-citationRixe, O., Ortuzar, W., Alvarez, M., Parker, R., Reed, E., Paull, K., & Fojo, T. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)81490-6 · Cited by 615
Inhibition of transcription by platinum antitumor compounds
Todd, R. C., & Lippard, S. J. (2009) · Metallomics · doi:10.1039/b907567d · Cited by 539
Self-citationDhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A., & Lippard, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9071282 · Cited by 510
Self-citationKnox, R. J., Friedlos, F., Lydall, D. A., & Roberts, J. J. (1986) · PubMed · Cited by 498
Beitrag zur Konstitution anorganischer Verbindungen
Werner, A. (1893) · Zeitschrift für anorganische Chemie · doi:10.1002/zaac.18930030136 · Cited by 474
Basis for Design and Development of Platinum(IV) Anticancer Complexes
Hall, M. D., Mellor, H. R., Callaghan, R., & Hambley, T. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070280u · Cited by 458
Crystal Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA
Takahara, P. M., Frederick, C. A., & Lippard, S. J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9625079 · Cited by 405
Self-citationPolymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9014032 · Cited by 400
What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt, E., & Gibson, D. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.06.013 · Cited by 370
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Dhar, S., & Lippard, S. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912276106 · Cited by 369
Self-citationPlatinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design
Reedijk, J. (2009) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200900054 · Cited by 343
Park, G. Y., Wilson, J. J., Song, Y., & Lippard, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207670109 · Cited by 330
Self-citationAng, W. H., Khalaila, I., Allardyce, C. S., Juillerat-Jeanneret, L., & Dyson, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0432618 · Cited by 314
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
Zutphen, S. V., & Reedijk, J. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.03.005 · Cited by 295
Arnesano, F., & Natile, G. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.01.028 · Cited by 282
Advances in Platinum Chemotherapeutics
Harper, B. W., Krause‐Heuer, A. M., Grant, M. P., Manohar, M., Garbutcheon‐Singh, K. B., & Aldrich‐Wright, J. R. (2010) · Chemistry – A European Journal · doi:10.1002/chem.201000148 · Cited by 267
Clinical Pharmacokinetics of Carboplatin
van der Vijgh, W. J. F. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121040-00002 · Cited by 263
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Self-citationGiandomenico, C. M., Abrams, M. J., Murrer, B. A., Vollano, J. F., Rheinheimer, M. I., Wyer, S. B., Bossard, G. E., & Higgins, J. D. (1995) · Inorganic Chemistry · doi:10.1021/ic00109a004 · Cited by 248
Lovejoy, K. S., Todd, R. C., Zhang, S., McCormick, M. S., D'Aquino, J. A., Reardon, J. T., Sancar, A., Giacomini, K. M., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803441105 · Cited by 238
Self-citationCisplatin nephrotoxicity: A review
Daugaard, G., & Abildgaard, U. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00694330 · Cited by 234
Lovejoy, K. S., & Lippard, S. J. (2009) · Dalton Transactions · doi:10.1039/b913896j · Cited by 230
Self-citationConjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
Mukhopadhyay, S., Barnés, C. M., Haskel, A., Short, S. M., Barnes, K. R., & Lippard, S. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc070031k · Cited by 226
Self-citationMonofunctional and Higher-Valent Platinum Anticancer Agents
Johnstone, T. C., Wilson, J. J., & Lippard, S. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400538c · Cited by 223
Self-citationCombating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201562 · Cited by 222
Spingler, B., Whittington, D. A., & Lippard, S. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010790t · Cited by 207
Self-citationZhang, J. Z., Wexselblatt, E., Hambley, T. W., & Gibson, D. (2012) · Chem. Commun. · doi:10.1039/c1cc16647f · Cited by 190
Biodegradable polymer − cisplatin(IV) conjugate as a pro-drug of cisplatin(II)
Xiao, H., Qi, R., Liu, S., Hu, X., Duan, T., Zheng, Y., Huang, Y., & Jing, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.072 · Cited by 187
Pt(IV) complexes as prodrugs for cisplatin
Shi, Y., Liu, S.-A., Kerwood, D. J., Goodisman, J., & Dabrowiak, J. C. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.10.012 · Cited by 179
Ueber die Einwirkung des Ammoniaks auf Platinchlorür
Peyrone, M. (1844) · Justus Liebigs Annalen der Chemie · doi:10.1002/jlac.18440510102 · Cited by 168
Towards Antitumor Active trans‐Platinum Compounds
Aris, S. M., & Farrell, N. P. (2009) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200801118 · Cited by 160
Bellon, S. F., & Lippard, S. J. (1990) · Biophysical Chemistry · doi:10.1016/0301-4622(90)80007-t · Cited by 148
Self-citationGramatica, P., Papa, E., Luini, M., Monti, E., Gariboldi, M. B., Ravera, M., Gabano, E., Gaviglio, L., & Osella, D. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0676-4 · Cited by 137
Diamminodichloroplatinum in the Chemotherapy of Testicular Tumors
Higby, D. J., Wallace, H. J., Albert, D. J., & Holland, J. F. (1974) · The Journal of Urology · doi:10.1016/s0022-5347(17)59652-4 · Cited by 135
Wang, D., Zhu, G., Huang, X., & Lippard, S. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002565107 · Cited by 133
Self-citationZhang, J., Bonnitcha, P., Wexselblatt, E., Klein, A. V., Najajreh, Y., Gibson, D., & Hambley, T. W. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201203159 · Cited by 130
Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
Yang, J. J., Sun, X., Mao, W., Sui, M., Tang, J., & Shen, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200597r · Cited by 127
Cumulative toxicities from cisplatin therapy and current cytoprotective measures
Cvitkovic, E. (1998) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(98)90061-5 · Cited by 119
Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate Complexes
Wilson, J. J., & Lippard, S. J. (2011) · Inorganic Chemistry · doi:10.1021/ic2000816 · Cited by 117
Self-citationAng, W. H., Pilet, S., Scopelliti, R., Bussy, F., Juillerat‐Jeanneret, L., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0506468 · Cited by 113
Reduction ofcis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by Aqueous Extracts of Cancer Cells
Nemirovski, A., Kasherman, Y., Ardeli‐Tzaraf, Y., & Gibson, D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070740j · Cited by 113
Todd, R. C., & Lippard, S. J. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.04.005 · Cited by 111
Self-citationExcursions in polynuclear platinum DNA binding
Mangrum, J. B., & Farrell, N. P. (2010) · Chemical Communications · doi:10.1039/c0cc01254h · Cited by 110
Gümüş, F., Eren, G., Açık, L., Çelebi, A., Küp, F. Ö., Yılmaz, Ş., Sağkan, R. I., Gür, S., Özkul, A., Elmalı, A., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8000983 · Cited by 108
Baruah, H., Barry, C. G., & Bierbach, U. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387313 · Cited by 108
Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
Graf, N., Mokhtari, T. E., Papayannopoulos, I. A., & Lippard, S. J. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.02.012 · Cited by 107
Self-citationNováková, O., Kasparkova, J., Malina, J., Natile, G., & Brabec, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg863 · Cited by 105
Farrell, N. P., Kiley, D. M., Schmidt, W., et al. (1990) · Inorganic Chemistry · doi:10.1021/ic00328a011 · Cited by 102
Clinical Status of Cisplatin, Carboplatin, and Other Platinum‐Based Antitumor Drugs
O'Dwyer, P. J., Stevenson, J. P., & Johnson, S. W. (1999) · doi:10.1002/9783906390420.ch2 · Cited by 101
Warnecke, A., Fichtner, I., Garmann, D., Jaehde, U., & Kratz, F. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049829j · Cited by 101
Tuning the Activity of Platinum(IV) Anticancer Complexes through Asymmetric Acylation
Chin, C. F., Tian, Q., Setyawati, M. I., Fang, W., Tan, E. S. Q., Leong, D. T., & Ang, W. H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300580y · Cited by 100
Transcription Inhibition by Platinum−DNA Cross-Links in Live Mammalian Cells
Ang, W. H., Myint, M., & Lippard, S. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja101495v · Cited by 97
Self-citationGold nanorods for platinum based prodrug delivery
Min, Y., Mao, C., Xu, D., Wang, J., & Liu, Y. (2010) · Chemical Communications · doi:10.1039/c0cc03108a · Cited by 95
Yang, J. J., Liu, W., Sui, M., Tang, J., & Shen, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.022 · Cited by 93
Wexselblatt, E., Yavin, E., & Gibson, D. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201300640 · Cited by 92
Duong, H. T. T., Huynh, V. T., SOUZA, P. D., & Stenzel, M. H. (2010) · Biomacromolecules · doi:10.1021/bm100396s · Cited by 91
Varbanov, H. P., Valiahdi, S. M., Legin, A. A., Jakupec, M. A., Roller, A., Galanski, M. S., & Keppler, B. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.006 · Cited by 84
Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery
Pichler, V., Mayr, J., Heffeter, P., Dömötör, O., Enyedy, E. A., Hermann, G., Groza, D., Köllensperger, G., Galanksi, M., Berger, W., et al. (2013) · Chemical Communications · doi:10.1039/c3cc39258a · Cited by 79
DNA Metalating–Intercalating Hybrid Agents for the Treatment of Chemoresistant Cancers
Suryadi, J., & Bierbach, U. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202050 · Cited by 77
Bierbach, U., Hambley, T. W., & Farrell, N. P. (1998) · Inorganic Chemistry · doi:10.1021/ic970420y · Cited by 77
ROCHON, F. D., & Gruia, L. M. (2000) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)00171-7 · Cited by 75
Baruah, H., Rector, C. L., Monnier, S. M., & Bierbach, U. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01107-3 · Cited by 74
Solid-phase synthesis of oxaliplatin–TATpeptide bioconjugates
Abramkin, S. A., Valiahdi, S. M., Jakupec, M. A., et al. (2012) · Dalton Transactions · doi:10.1039/c2dt12024k · Cited by 69
Kralingen, C. G. V., RIDDER, J. K. D., & Reedijk, J. (1979) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)89373-1 · Cited by 69
Huxley, M., Sánchez-Cano, C., Browning, M. J., Navarro‐Ranninger, C., Quiroga, A. G., Rodger, A., & Hannon, M. J. (2010) · Dalton Transactions · doi:10.1039/c0dt00838a · Cited by 66
Kinetics of nickel, palladium and platinum complexes
Peloso, A. (1973) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(00)80233-7 · Cited by 64
Gaviglio, L., Groß, A., Metzler‐Nolte, N., & Ravera, M. (2012) · Metallomics · doi:10.1039/c2mt00171c · Cited by 62
Ma, E. S. F., Bates, W. D., Edmunds, A., Kèlland, L. R., Fojo, T., & Farrell, N. P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050539d · Cited by 49
Harnessing chemoselective imine ligation for tethering bioactive molecules to platinum(iv) prodrugs
Wong, D. Y. Q., Lau, J. Y., & Ang, W. H. (2012) · Dalton Transactions · doi:10.1039/c2dt30264k · Cited by 48
Chemistry and Biological Activity of Platinum Amidine Complexes
Michelin, R. A., Sgarbossa, P., Sbovata, S. M., Gandin, V., Marzano, C., & Bertani, R. (2011) · ChemMedChem · doi:10.1002/cmdc.201100150 · Cited by 47
Westendorf, A. F., Zerzánková, L., Salassa, L., Sadler, P. J., Brabec, V., & Bednarski, P. J. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.01.003 · Cited by 45
The Intimate Mechanism of Replacements in d 8 Square‐Planar Complexes
Cattalini, L. (1970) · Progress in inorganic chemistry · doi:10.1002/9780470166147.ch6 · Cited by 41
Reithofer, M. R., Valiahdi, S. M., Galanski, M. S., Jakupec, M. A., Arion, V. B., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890197 · Cited by 41
Sbovata, S. M., Bettìo, F., Mozzon, M., Bertani, R., Venzo, A., Benetollo, F., Michelin, R. A., Gandin, V., & Marzano, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070426p · Cited by 39
Marzano, C., Sbovata, S. M., Gandin, V., Colavito, D., Giudice, E. D., Michelin, R. A., Venzo, A., Seraglia, R., Benetollo, F., Schiavon, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1006534 · Cited by 33
Littlefield, S. L., Baird, M. C., Anagnostopoulou, A., & Raptis, L. H. (2008) · Inorganic Chemistry · doi:10.1021/ic702057q · Cited by 27
Benedetti, B. T., Quintal, S., & Farrell, N. P. (2011) · Dalton Transactions · doi:10.1039/c1dt10964b · Cited by 17
Plíhalová, L., Trávníček, Z., Popa, I., & Marek, J. (2008) · Polyhedron · doi:10.1016/j.poly.2008.05.021 · Cited by 16
Mukhopadhyay, U., Thurston, J. H., Whitmire, K. H., & Khokhar, A. R. (2002) · Polyhedron · doi:10.1016/s0277-5387(02)01214-7 · Cited by 11
Monodentate amine complexes of platinum(II)
Beaumont, K. P., & McAuliffe, C. A. (1974) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)92604-5 · Cited by 9
Failes, T. W., Battle, A. R., Chen, C., et al. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.04.010 · Cited by 2
Cited by
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Self-citationCisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials
Weinstain, R., Slanina, T., Kand, D., & Klán, P. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00663 · Cited by 642
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Zheng, Y.-R., Suntharalingam, K., Johnstone, T. C., Yoo, H., Lin, W., Brooks, J. G., & Lippard, S. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5038269 · Cited by 440
Self-citation
Metadata
- Authors
- Wilson, J. J., & Lippard, S. J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-11-27
- Volume
- 114
- Issue
- 8
- Pages
- 4470-4495
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W1596555085
- Cited by
- 630
- References
- 101
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.